SCHEMBL14034299

SCHEMBL14034299

CC(=O)OCC1OC(n2c(C)nc3c(N)ncnc32)C(OC(C)=O)C1OC(C)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
AMD1 P17707 9/20 0.52
LMNA P02545 2/20 0.52
MAPT P10636 2/20 0.52
TP53 P04637 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
PRKAB2 O43741 1/20 0.47
PRKAG1 P54619 1/20 0.47
PRKAA2 P54646 1/20 0.47
PRKAA1 Q13131 1/20 0.47
PRKAG3 Q9UGI9 1/20 0.47
PRKAG2 Q9UGJ0 1/20 0.47
PRKAB1 Q9Y478 1/20 0.47
THRB P10828 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
RNASEL Q05823 3/20 0.46
HSPA5 P11021 1/20 0.45
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31685464 0.92 ALDH1A1 (0.54) ALDH1A1AMD1LMNAMAPTTP53
SCHEMBL1096926 0.90 ALDH1A1 (0.67) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL1135348 0.90 ALDH1A1 (0.67) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL10602827 0.90 ALDH1A1 (0.52) ALDH1A1AMD1LMNAMAPTTP53
SCHEMBL6275982 0.90 ALDH1A1 (0.55) ALDH1A1AMD1LMNAMAPTTP53
SCHEMBL1096927 0.90 ALDH1A1 (0.67) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL1106671 0.90 ALDH1A1 (0.67) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL7953881 0.90 ALDH1A1 (0.52) ALDH1A1AMD1LMNAMAPTTP53
SCHEMBL1096889 0.89 ALDH1A1 (0.51) ALDH1A1AMD1LMNAMAPTTP53
SCHEMBL1096885 0.89 ALDH1A1 (0.51) ALDH1A1AMD1LMNAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293665-A1 Purine Nucleotide Derivatives LAURAS AS (NO) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293665-A1 Purine Nucleotide Derivatives CGAS, PDE8A, PDE7A ALDH1A1 3225/4885AMD1 820/4885LMNA 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.